ONC BeOne Medicines Ltd.
Healthcare$304.55+0.00%OpenMarket Cap: $32.54B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$397.89
Target (Median)
$409.00
Target Range
$340.00 - $425.00
Upside from current price: 30.6%
Rating Distribution
8 Strong Buy19 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-05-07 | Truist Securities | maintain | Buy | Buy |
| 2026-05-07 | Guggenheim | maintain | Buy | Buy |
| 2026-05-07 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-07 | Barclays | maintain | Overweight | Overweight |
| 2026-03-16 | Jefferies | downgrade | Hold | Buy |
| 2026-02-27 | Barclays | maintain | Overweight | Overweight |
| 2026-02-27 | Guggenheim | maintain | Buy | Buy |
| 2026-02-27 | RBC Capital | maintain | Outperform | Outperform |
| 2026-02-27 | Truist Securities | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $9.56 | $7.49B | 12 |
| Sun Dec 31 | $12.88 | $8.49B | 12 |
| Mon Dec 31 | $14.92 | $9.33B | 10 |
| Tue Dec 31 | $18.73 | $10.44B | 5 |